Kamran Miah

Kamran Miah is a Senior Post-Doctoral Research Scientist at the University of Oxford's Nuffield Department of Clinical Laboratory Science, affiliated with the Gene Medicine Group. His work focuses on lentiviral vector development for gene therapy applications.

• University: University of Reading (PhD), University College London (MSc), Brunel University (BSc)

His research centers on gene therapy for respiratory diseases, including:

• Development of Sendai virus-pseudotyped lentiviral vectors for Cystic Fibrosis treatment
• CRISPR/Cas9 targeting of YB1 in AAV vector production
• Characterization of viral vectors for clinical trials

Prominent publication trends include:

• Advancements in respiratory gene therapy (2022)
• Comparative studies of viral vector systems (2019)
• Immunological responses to SARS-CoV-2 (2022)